Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $241.45 million. The enterprise value is $179.86 million.

Market Cap	241.45M
Enterprise Value	179.86M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BNTC has 23.22 million shares outstanding. The number of shares has increased by 250.17% in one year.

Current Share Class	23.22M
Shares Outstanding	23.22M
Shares Change (YoY)	+250.17%
Shares Change (QoQ)	+19.70%
Owned by Insiders (%)	6.28%
Owned by Institutions (%)	33.32%
Float	12.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.97
P/TBV Ratio	3.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.01, with a Debt / Equity ratio of 0.00.

Current Ratio	15.01
Quick Ratio	14.90
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.23% and return on invested capital (ROIC) is -32.12%.

Return on Equity (ROE)	-48.23%
Return on Assets (ROA)	-29.23%
Return on Capital (ROIC)	-32.12%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +210.79% in the last 52 weeks. The beta is 0.88, so BNTC's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+210.79%
50-Day Moving Average	9.99
200-Day Moving Average	7.90
Relative Strength Index (RSI)	53.05
Average Volume (20 Days)	32,280

Short Selling Information

Short Interest	56,887
Short Previous Month	38,171
Short % of Shares Out	0.25%
Short % of Float	0.44%
Short Ratio (days to cover)	1.35

Income Statement

Revenue	n/a
Gross Profit	2,000
Operating Income	-22.41M
Pretax Income	-21.69M
Net Income	-20.86M
EBITDA	-22.31M
EBIT	-22.41M
Earnings Per Share (EPS)	-$3.38

Full Income Statement

Balance Sheet

The company has $67.84 million in cash and $211,000 in debt, giving a net cash position of $67.63 million or $2.91 per share.

Cash & Cash Equivalents	67.84M
Total Debt	211,000
Net Cash	67.63M
Net Cash Per Share	$2.91
Equity (Book Value)	64.18M
Book Value Per Share	3.59
Working Capital	63.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.41 million and capital expenditures -$179,000, giving a free cash flow of -$19.59 million.

Operating Cash Flow	-19.41M
Capital Expenditures	-179,000
Free Cash Flow	-19.59M
FCF Per Share	-$0.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-291,200.00%

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-250.17%
Shareholder Yield	-250.17%
Earnings Yield	-8.64%
FCF Yield	-8.11%

Dividend Details

Analyst Forecast

The average price target for BNTC is $22.60, which is 117.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.60
Price Target Difference	117.31%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date	Jul 26, 2023
Split Type	Reverse
Split Ratio	0.0588235:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2